Login / Signup
Yiwen Zhou
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Cancer Therapy
Locally Advanced
Vascular Endothelial Growth Factor
Tyrosine Kinase
Top Venues
Exploration of targeted anti-tumor therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yiwen Zhou
,
Jingjing Li
,
Jieer Ying
Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis.
Exploration of targeted anti-tumor therapy
5 (3) (2024)
Yiwen Zhou
,
Jingjing Li
,
Jieer Ying
Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis.
Exploration of targeted anti-tumor therapy
5 (3) (2024)